Latest Breaking News On - Bristol myer squibb - Page 1 : vimarsana.com

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

Novel CAR-T Cell Therapy Trial for Lupus Launched by Atlantic Health System

Mohamed Cherry, MD, and Neil Kramer, MD, shed light on a phase 1 trial using CAR-T cell therapy for SLE and its potential implications for lupus treatment.

Bristol Myers Squibb invests over $400m in sterile drug product facility

Bristol Myers Squibb is investing over $400 million to build a sterile drug product facility at its Dublin campus.

Bristol Myers Squibb to invest $440m in Dublin facility

Cooley's 2023 Life Sciences M&A Year In Review: Potent Mix Of Creativity And Resilience Spurs Activity Heading Into 2024 - Corporate and Company Law

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024.

Cooley's 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024 | Cooley LLP

In a subdued year for global M&A, deal-making in the life sciences industry came in waves, with a busy fourth quarter generating cautious optimism heading into 2024. While the year saw...

A Critical Convergence of Expertise in Seattle's Biotech Ecosystem – GeekWire

Cytokinetics Stock Jumps To Higher RS Level; Shoots Up On Heart Drug Study

PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion – IT Business Net

Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics

Transaction Delivers KarXT, a First-in-Class M1 / M4 Muscarinic Receptor Agonist, with Differentiated Efficacy and Safety KarXT Is a Potential First-in-Class Treatment for Schizophrenia and as an...